Hypothesis on Management of Coronavirus Disease  

作　　者：Majid Rezaei Basiri 

机构地区：[1]Department of Pharmacology-Toxicology,Pharmacy School,University of Medical Sciences,Tabriz,Iran [2]Department of Pharmacology,School of Medicine,University of Medical Sciences,Tehran,Iran [3]Welfare Organization of East Azarbayjan,Tabriz,Iran

出　　处：《Journal of Pharmacy and Pharmacology》2022年第4期120-124,共5页药剂与药理学（英文版）

基　　金：We acknowledge that all patients infected with coronavirus and victims.The economy problems of infected families with coronavirus are very serious,and it must be solved through government organizations。

摘　　要：Coronaviruses are++strand enveloped RNA viruses with an unusually large genome.Viruses connect to cell surface with spike protein.The spike protein is has important role to recognizable part of the virus.Virus structure primary make CMI then humoral immunity.When the immune system makes Antibodies against to glycoprotein S(spike),they can disable the entire virus.Some of viral infections are endoparasits in human body cells and it might be make chronic damages.Most common symptoms diseases are:fever,cough,tiredness,loss of taste or smell.The golden standard Diagnostic Panel tests are Real-Time Reverse Transcriptase(RT)-PCR tests in all countries.The combination therapy include convalescent plasma(CCP),NSAIDs,paracetamol,codeine,corticosteroids,Herbal,antivirals,vitamins,systemic interferons,monoclonal antibodies against components of the immune system such as interleukins storm,other immune modulators,and monoclonal antibodies against components of corona disease.

关 键 词：Coronavirus disease MANAGEMENT immune response TREATMENT side effects 

分 类 号：R73[医药卫生—肿瘤]